Barclays
BNGO icon

Barclays’s Bionano Genomics BNGO Stock Holding History

Barclays’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3 Buy
+3
New +$4 ﹤0.01% 5315
2025
Q2 		– Sell
-3
Closed -$8 – 5273
2025
Q1 		$8 Hold
3
– – ﹤0.01% 5183
2024
Q4 		$58 Hold
3
– – ﹤0.01% 5194
2024
Q3 		$91 Hold
3
– – ﹤0.01% 5185
2024
Q2 		$136 Hold
3
– – ﹤0.01% 4745
2024
Q1 		$222 Hold
3
– – ﹤0.01% 4983
2023
Q4 		$378 Buy
+3
New +$313 ﹤0.01% 5140
2023
Q3 		– Sell
-3
Closed -$1.22K – 4605
2023
Q2 		$1.22K Sell
3
-253
-99% -$114K ﹤0.01% 4354
2023
Q1 		$171K Buy
256
+119
+87% +$106K ﹤0.01% 3886
2022
Q4 		$120K Buy
137
+113
+471% +$142K ﹤0.01% 4123
2022
Q3 		$27K Sell
24
-4
-14% -$5.29K ﹤0.01% 3967
2022
Q2 		$23K Sell
28
-57
-67% -$58.6K ﹤0.01% 4334
2022
Q1 		$130K Sell
85
-509
-86% -$687K ﹤0.01% 3667
2021
Q4 		$1.06M Buy
594
+398
+203% +$1.06M ﹤0.01% 2791
2021
Q3 		$645K Buy
196
+101
+106% +$353K ﹤0.01% 3045
2021
Q2 		$417K Buy
95
+91
+2,275% +$359K ﹤0.01% 3175
2021
Q1 		$17K Buy
+4
New +$22.6K ﹤0.01% 4392
2020
Q4 		– Sell
-1
Closed -$374 – 4891
2020
Q3 		$0 Sell
1
-199
-100% -$77.2K ﹤0.01% 5229
2020
Q2 		$61K Buy
+200
New +$50.2K ﹤0.01% 4834

Other funds holding BNGO

GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Barclays's BNGO Position: Q2 2026 in Review

Barclays opened a new position in Bionano Genomics (BNGO) in Q2 2026: 3 shares worth $3. The stake represents ﹤0.01% of the portfolio and ranks #5315 among its holdings. This is a return to the name: Barclays previously reported a position in BNGO as recently as Q1 2025.

Barclays first reported a position in BNGO in Q2 2020 and has held it in 19 quarters since. The position peaked at $1.06M in Q4 2021. 34 funds tracked by Wall St. Rank hold BNGO as of Q2 2026.

  • Barclays held 3 shares of Bionano Genomics worth $3 as of Q2 2026.
  • Bionano Genomics was a new Barclays position in Q2 2026.
  • Bionano Genomics made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #5315 holding.
  • Barclays first reported a position in Bionano Genomics in Q2 2020 and has held it in 19 quarters since.
  • Barclays's Bionano Genomics position peaked at $1.06M in Q4 2021.
  • 34 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.